Related Experiment Video
Updated: Jun 16, 2026
10:20
Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
Inflammation and pulmonary hypertension.
1Section of Pediatric Cardiology, Maria Fareri Children's Hospital, New York Medical College, Valhalla, NY 10595, USA. rajamma_mathew@NYMC.edu
Cardiology in Review
|February 18, 2010
Summary
Inflammation contributes to pulmonary hypertension (PH) by causing endothelial dysfunction. Loss of endothelial caveolin-1 in PH exacerbates this by removing antiproliferative signals, leading to vascular cell overgrowth.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Biology
Background:
- Pulmonary hypertension (PH) is a severe condition with significant morbidity and mortality.
- Inflammation is increasingly recognized as a key factor in PH development.
- Endothelial dysfunction, characterized by an imbalance in vascular tone and cell proliferation, is a central feature of PH.
Purpose of the Study:
- To explore the role of inflammation in the pathogenesis of pulmonary hypertension.
- To investigate the function of endothelial caveolin-1 in PH.
- To examine the potential link between inflammation and endothelial caveolin-1 in PH.
Main Methods:
- Review of existing literature on inflammation, endothelial dysfunction, and caveolin-1 in PH.
- Analysis of studies reporting on inflammatory cytokine up-regulation and perivascular cell infiltration in PH.
- Examination of research on caveolin-1 expression in human and experimental PH models.
Main Results:
- Inflammatory cytokines contribute to endothelial dysfunction, a hallmark of PH.
- Loss of endothelial caveolin-1, an inhibitor of cell proliferation, is observed in PH.
- Reduced caveolin-1 expression leads to loss of antiproliferative activity and deregulated vascular cell proliferation.
Conclusions:
- Inflammation plays a critical role in the development of pulmonary hypertension.
- Endothelial caveolin-1 is a crucial factor in regulating vascular cell proliferation and may be a key player in the interplay between inflammation and PH.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.